Advertisement

Topics

PCSK9 Therapy in Diabetes: New Context

06:27 EDT 21 Aug 2017 | Medscape

Dr Robert Eckel reviews research from ADA 2017 on alirocumab in patients with diabetes and mixed dyslipidemia.
Endocrine Society

Original Article: PCSK9 Therapy in Diabetes: New Context

NEXT ARTICLE

More From BioPortfolio on "PCSK9 Therapy in Diabetes: New Context"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...